A Psychonaut's Experience of Intoxication with Multiple Classes of Drugs Including Novel Psychoactive Substance 2-fluorodeschloroketamine: Case Report and Urinary Analysis.
Journal of psychoactive drugs – January 01, 2022
Source: PubMed
Summary
A concerning case reveals 2-fluorodeschloroketamine (2-FDCK), a novel psychoactive substance and ketamine derivative, is now appearing in the United States. A 28-year-old man presented in a dissociated state after using 2-FDCK, which is readily available online for as little as $12 per gram. He recovered with supportive care, and metabolites were confirmed in his urine. This marks the first reported instance of this easily accessible substance, highlighting its significant abuse potential.
Abstract
Novel psychoactive substances have emerged as drugs of abuse. 2-Fluorodeschloroketamine (2-FDCK) is a ketamine derivative that can be purchased online for as little as $12 per gram. We report the case of a patient with a history of polysubstance use presenting after insufflation of 2-FDCK, with subsequent confirmation of metabolites in the patient's urine. A 28-year-old man presented to the Emergency Department in a dissociated state. He recovered well with supportive care, and described during interview his experience of substance use including the novel psychoactive substance 2-FDCK. A urine sample was sent for analysis and 2-FDCK metabolites were isolated. This case is concerning because 2-FDCK is a relatively new agent that has not yet been reported in the United States. It is easy to obtain over the internet and has significant abuse potential.